Senti Biosciences Stock Near $1: FDA Signal and Cash Test Put SNTI Back on Watch
Senti Biosciences Holdings Inc. shares edged higher in U.S. premarket trading Tuesday, holding near the $1 line as Wall Street came back from the Memorial Day break and investors weighed a recent FDA update against the biotech’s funding needs. The Nasdaq-listed stock was quoted at $0.9961 at 04:08 EDT, after closing Friday at $0.9869, up 0.28%; it slipped about 2.3% last week despite an 11.3% rebound on Wednesday. The timing matters because Monday was not a normal trading pause. Nasdaq’s U.S. equity and options markets were closed on May 25 for Memorial Day, leaving Tuesday as the first regular session after Friday’s close.